Compare Dominion Energy Inc (D) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dominion Energy Inc vs Sanofi SA — how do they compare? Dominion Energy Inc trades at $61.65 (market cap $54.31B), while Sanofi SA trades at $40.04 (market cap $95.18B). The key difference: Sanofi SA is the larger of the two by market cap, and Sanofi SA pays the higher dividend (6.01%). Which is the better fit depends on your goals — on Pluang, investors hold Dominion Energy Inc for 76 Days and Sanofi SA for 94 Days on average.
| D | SNY | |
|---|---|---|
Market Cap | $54.31B | $95.18B |
Volume | 6,944,775 | 2,995,646 |
Sector | Utilities | Health |
52-Week High | $71.67 | $52.34 |
52-Week Low | $57.08 | $39.51 |
Typical Hold Time | 76 Days | 94 Days |
Enterprise Value | $108.43B | $114.48B |
Dividend Yield | 4.32% | 6.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dominion Energy (D) trades at $61.64, up 0.18% with a bearish technical signal despite recent earnings beats. The company shows strong fundamentals with 2025 revenue of $16.51B and net income of $3.00B, representing an 18.16% profit margin. Analyst consensus is mixed with 36% buy ratings but a $71.56 price target suggesting 16% upside. Key developments include the pending $67B merger with NextEra Energy and a $0.67 dividend payment scheduled for September 2026.
The stock presents a value opportunity with reasonable valuation metrics (P/E 21.37, P/S 2.96) and consistent profitability, though technical indicators signal near-term caution. The NextEra merger represents significant upside potential but carries regulatory approval risks. Current levels offer attractive entry for long-term investors seeking utility exposure with dividend income.
Sanofi (SNY) trades at $40.07, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.21 exceeding the $1.10 estimate. Revenue for 2025 reached $46.72 billion, with a net income margin of 16.72%. Recent news highlights a significant $8 billion immunology alliance expansion with Regeneron, signaling strategic growth initiatives.
The outlook is mixed; solid profitability and a strategic partnership provide upside potential, but a projected net income decline to $4.0 billion in 2026 and bearish technical indicators pose risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, though investors should monitor execution of new collaborations and patent expiration impacts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dominion Energy Inc
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
